KARMA Kontrast Evaluating Contrast Enhanced Mammography in Early Detection of Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

April 1, 2024

Study Completion Date

May 31, 2024

Conditions
Breast Cancer
Interventions
COMBINATION_PRODUCT

Contrast Enhanced Mammography

A modality for examining breast conditions which is already approved and used but the evaluation of its role in a recalled screening population is limited. Intravenous iodine contrast is given prior to the mammogram.

Trial Locations (1)

Unknown

RECRUITING

Bröstcentrum, Södersjukhuset, Stockholm

All Listed Sponsors
collaborator

Stockholm South General Hospital

OTHER

lead

Karolinska Institutet

OTHER